{"id":"https://genegraph.clinicalgenome.org/r/ba8a19e6-74cc-4b4e-883f-0b851ad03943v1.0","type":"EvidenceStrengthAssertion","dc:description":"*MCAT* was first reported in relation to autosomal recessive optic atrophy 15 (MIM #620583) in 2020 (Li et al., PMID: 31915829). At least four variants (missense and frameshift) have been reported in two probands in two publications (PMID: 31915829, PMID: 33918393). One proband has a brother who shares the genotype and phenotype, but no other segregations are available from this family to enable scoring of co-segregation. Variants in *MCAT* have been reported in individuals with autosomal recessive optic atrophy 15 and one proband asserted to have combined oxidative phosphorylation deficiency. Per criteria outlined by the ClinGen Lumping & Splitting Working Group, we found insufficient evidence of difference in molecular mechanism or inheritance pattern despite phenotypic variability of the probands. The combined oxidative phosphorylation deficiency case reported in Webb et. al 2023 is known to the group and was reviewed as a part of lumping and splitting (PMID:36881526). Although there is insufficient evidence to split the entities, the Webb case is not scored in this curation due to a lack of information about the ocular phenotype. Furthermore, the age of the proband at the time of the report and this curation is younger than the expected age of onset for the disease. \n\nThis gene-disease relationship is supported by functional alteration experimental evidence and a mouse model (PMID: 31915829). The effects of overexpression of the individual variant and variant pair in HEK293T cells was monitored through immunostaining and immunoelectron microscopy demonstrating that the mitochondria of cells transfected with either *MCAT* Leu81Arg and *MCAT* Leu81Arg/Arg212Trp were thinner than those of wild type *MCAT* cells. This showed that the expression of the mutants had a damaging effect on mitochondrial inner membrane morphology (PMID: 31915829). An *MCAT* floxed mouse (MCATt-Flox+/+, PMID: 23077570) was treated with adeno-associated virus 2 (AAV2)-Cre to knock out *MCAT* specifically in retinal ganglion cells. The results showed that depletion of *MCAT* expression in the mitochondria of the retinal ganglion cells disrupts maintenance of retinal ganglion cell axons, helping to explain a disruption in the relevant tissue observed in human probands (PMID: 31915829).\n\nIn summary, there is limited evidence to support the gene-disease relationship between *MCAT* and optic atrophy 15. Although more evidence from cases with *MCAT* variants will be needed to support a more definitive classification, no convincing evidence has  yet emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Glaucoma and Neuro-Ophthalmology Gene Curation Expert Panel on May 16th, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ba8a19e6-74cc-4b4e-883f-0b851ad03943","GCISnapshot":"https://genegraph.clinicalgenome.org/r/427c818a-1705-4013-a5ba-d977540535d5","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/427c818a-1705-4013-a5ba-d977540535d5_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10077","date":"2024-05-16T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/427c818a-1705-4013-a5ba-d977540535d5_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10077","date":"2025-01-06T03:51:02.871Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/427c818a-1705-4013-a5ba-d977540535d5_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d53fe227-e6db-4d23-8edd-8beb305fbaab_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/228f88a9-0f0e-46f3-a04d-4d05dec4cb33","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/228f88a9-0f0e-46f3-a04d-4d05dec4cb33_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression of Flag-tagged R212W in HEK293T cells was shown to be about 74% of WT MCAT expression. However, in the proband both variants are present in tandem on both alleles; Expression of Flag-tagged L81R/R212W was about 39% of WT MCAT expression.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/228f88a9-0f0e-46f3-a04d-4d05dec4cb33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31915829","allele":{"id":"https://genegraph.clinicalgenome.org/r/616ddcee-302d-4400-962a-0815377ddcaf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_173467.5(MCAT):c.634C>T (p.Arg212Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10272524"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/28c02618-9f47-4c55-8697-c66f08ab393a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28c02618-9f47-4c55-8697-c66f08ab393a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression of Flag-tagged L81R in HEK293T cells was shown to be about 47% of WT MCAT expression. However, in the proband both variants are present in tandem on both alleles; Expression of Flag-tagged L81R/R212W was about 39% of WT MCAT expression. \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/28c02618-9f47-4c55-8697-c66f08ab393a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31915829","allele":{"id":"https://genegraph.clinicalgenome.org/r/d885eee0-747d-462e-9d56-26bae6fc1624","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_173467.5(MCAT):c.242T>G (p.Leu81Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10272667"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d53fe227-e6db-4d23-8edd-8beb305fbaab","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31915829","rdfs:label":"Li Family V2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/616ddcee-302d-4400-962a-0815377ddcaf"},{"id":"https://genegraph.clinicalgenome.org/r/d885eee0-747d-462e-9d56-26bae6fc1624"}],"phenotypeFreeText":"Gradual vision loss. Fundoscopic examination of patients showed attenuated capillaries of optic disc. Optical coherence tomography (OCT) revealed severe bilateral reduction of nerve fiber layer thickness in all quadrants around the optic disc in patients (avg 54 Î¼m). ","phenotypes":["obo:HP_0000639","obo:HP_0000648","obo:HP_0012512"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/228f88a9-0f0e-46f3-a04d-4d05dec4cb33_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/28c02618-9f47-4c55-8697-c66f08ab393a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/226d15fd-0a1b-4308-a02d-f37c287d8b09_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7047bb9-2d87-409e-b492-9edfb005148a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7047bb9-2d87-409e-b492-9edfb005148a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33918393","allele":{"id":"https://genegraph.clinicalgenome.org/r/2bba6f14-13d4-44d7-89af-10b9ed97f2b2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_173467.5(MCAT):c.1039G>A (p.Glu347Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10272406"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3ebdedc8-a361-402f-936b-ffbf5a46b191","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ebdedc8-a361-402f-936b-ffbf5a46b191_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Splicing score predictions for variant in Supplementary Figure 1. ","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/3ebdedc8-a361-402f-936b-ffbf5a46b191_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33918393","allele":{"id":"https://genegraph.clinicalgenome.org/r/e17d58e7-3fc3-457b-a6f4-f415496e0b4c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_173467.5(MCAT):c.424-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411823195"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/226d15fd-0a1b-4308-a02d-f37c287d8b09","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33918393","rdfs:label":"Gerber Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":20,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e17d58e7-3fc3-457b-a6f4-f415496e0b4c"},{"id":"https://genegraph.clinicalgenome.org/r/2bba6f14-13d4-44d7-89af-10b9ed97f2b2"}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Retinal nerve fibre layer optical coherence tomography revealed a dramatic generalized reduction in optic nerve fibers. Brain MRI (age 20) showing optic nerve hypersignals extending to the chiasma, particularly on the left side.","phenotypes":["obo:HP_0000649","obo:HP_0000603","obo:HP_0000552","obo:HP_0002315","obo:HP_0000613","obo:HP_0007663"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e7047bb9-2d87-409e-b492-9edfb005148a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3ebdedc8-a361-402f-936b-ffbf5a46b191_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/427c818a-1705-4013-a5ba-d977540535d5_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fec358bb-f168-4adf-ae7e-b465305ca7e8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31915829","rdfs:label":"Li Family","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/fec358bb-f168-4adf-ae7e-b465305ca7e8","type":"Family","rdfs:label":"Li Family","member":{"id":"https://genegraph.clinicalgenome.org/r/d53fe227-e6db-4d23-8edd-8beb305fbaab"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/d53fe227-e6db-4d23-8edd-8beb305fbaab"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.6},{"id":"https://genegraph.clinicalgenome.org/r/427c818a-1705-4013-a5ba-d977540535d5_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/427c818a-1705-4013-a5ba-d977540535d5_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efcfd58b-430a-4d35-8ec5-11e6040fd370","type":"EvidenceLine","dc:description":"Score reduced because of lack of quantitative data and no demonstration of the axon structure. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb2c8189-3786-4c13-b780-2dcb397dc6ab","type":"Finding","dc:description":"The results showed that the depletion of MCAT expression in the mitochondria of the retinal ganglion cells disrupts maitenence of RGC axons. This explains a disruption in the relevant tissue of the human phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31915829","rdfs:label":"Li RGC Knockout Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/427c818a-1705-4013-a5ba-d977540535d5_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15720950-4f8b-43a0-81b7-a0d685c4d857","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ae83c11-ac30-4140-9440-23d93a645614","type":"FunctionalAlteration","dc:description":"The alteration was first detected by monitoring the mitochondria structure of COX4 in HEK293T cells transfected with the variant via immunostaining. These results were further investigated with immunoelectron microscopy.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31915829","rdfs:label":"Li Intracellular Localization"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Limited","sequence":9705,"specifiedBy":"GeneValidityCriteria10","strengthScore":4.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/MfuhYzCKp34","type":"GeneValidityProposition","disease":"obo:MONDO_0957935","gene":"hgnc:29622","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_427c818a-1705-4013-a5ba-d977540535d5-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}